Results 131 to 140 of about 9,093,113 (302)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Monograph in 'BID' on data webs and knowledge graphs

BiD: Textos Universitaris de Biblioteconomia i Documentació, 2023
Miquel Centelles Velilla
doaj   +1 more source

Open access : un cambio de paradigma para la puesta a disposición pública del conocimiento. El desarrollo en Alemania

BiD: Textos Universitaris de Biblioteconomia i Documentació, 2007
La principal característica de open access consiste en que el aprovechamiento del conocimiento procedente del ámbito de educación y ciencia, que ha sido hecho público y se ha producido con fondos públicos, es libre (también en el sentido deThe main ...
Kuhlen, Rainer
doaj  

Autonomous Power Decision for the Grant Free Access MUSA Scheme in the mMTC Scenario. [PDF]

Sensors (Basel), 2020
Ameur WB, Mary P, Hélard JF, Dumay M, Schwoerer J.   +4 more
europepmc   +1 more source

Laying Performance, Egg Quality Characteristics, and Egg Yolk Fatty Acids Profile in Layer Hens Housed with Free Access to Chicory- and/or White Clover-Vegetated or Non-Vegetated Areas. [PDF]

Animals (Basel), 2021
Kop-Bozbay C, Akdag A, Bozkurt-Kiraz A, Gore M, Kurt O, Ocak N.   +5 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Open access : un canvi de paradigma per posar a disposició pública el coneixement. El desenvolupament a Alemanya

BiD: Textos Universitaris de Biblioteconomia i Documentació, 2007
La característica principal d'open access és que l'aprofitament del coneixement procedent de l'àmbit d'educació i ciència, que s'ha fet públic i s'ha produït amb fons públics, és lliure (també en el sentit deThe main characteristic of Open Access ...
Kuhlen, Rainer
doaj  

The Costs and Benefits of Duty-Free, Quota-Free Market Access for Poor Countries: Who and What Matters [PDF]

This paper examines the potential benefits and costs of providing duty-free, quota-free market access to the least developed countries (LDCs), and the effects of extending eligibility to other small and poor countries. Using the MIRAGE computable general
Antoine Bouët, David Laborde Debucquet,Elisa Dienesch, and Kimberly Elliott
core   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source